Skip to main content
Clinical Trials/NCT02727140
NCT02727140
Completed
Not Applicable

Yoga as a Supportive Therapy for Patients With Hypertension: A Randomized Controlled Trial

Universität Duisburg-Essen1 site in 1 country75 target enrollmentMay 2016
ConditionsHypertension

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Hypertension
Sponsor
Universität Duisburg-Essen
Enrollment
75
Locations
1
Primary Endpoint
24 h mean value of systolic and diastolic blood pressure
Status
Completed
Last Updated
9 years ago

Overview

Brief Summary

The proposed study aims to investigate the feasibility, effectiveness, and perceived benefit of a supportive hatha yoga intervention for patients with hypertension using antihypertensive drugs. Patients will be randomized into 3 groups comparing hatha yoga with yoga postures, breathing and relaxation techniques to a hatha yoga intervention without yoga postures (only breathing and relaxation techniques) as well as to a wait list control group.

Registry
clinicaltrials.gov
Start Date
May 2016
End Date
April 2017
Last Updated
9 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Holger Cramer

Research director

Universität Duisburg-Essen

Eligibility Criteria

Inclusion Criteria

  • essential Hypertension
  • stable antihypertensive medication during the next 6 months

Exclusion Criteria

  • pregnancy or breast feeding
  • simultaneous participation in further clinical intervention trials
  • regular yoga practice in the past 12 months
  • serious mental illness (severe depression, severe addiction, psychosis)
  • manifest coronary heart disease that has been treated in the past 3 months or myocardial infarction, embolism of pulmonary arteries or stroke in the past 3 months
  • heart failure ≥ state 1 New York Heart Association (NYHA)
  • peripheral arterial occlusive disease ≥ state 1
  • renal insufficiency \> state 2, glomerular filtration rate \< 60 ml/min/1,73m² according to he National Kidney Foundation (NKF)

Outcomes

Primary Outcomes

24 h mean value of systolic and diastolic blood pressure

Time Frame: 12 weeks

Secondary Outcomes

  • Health-related Quality of Life(28 weeks)
  • Subjective Stress(28 weeks)
  • Adverse Events(28 weeks)
  • 24 h mean value of systolic and diastolic blood pressure(28 weeks)
  • Emotional Distress(28 weeks)
  • Nutrition habits(28 weeks)
  • Physical activity(28 weeks)

Study Sites (1)

Loading locations...

Similar Trials